C07D 335/08
Naphthothiopyrans
Official title: Naphthothiopyrans; Hydrogenated naphthothiopyrans
C07D335/08 (Naphthothiopyrans) appears on 22 US grants and 18 published applications in this corpus.
Search patents in C07D- Granted patents
- 22
- Published applications
- 18
- Assignees
- 18
- Inventors
- 78
- Latest grant
- 15 Oct 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 2 | 1 |
| 2004 | 0 | 3 |
| 2005 | 1 | 2 |
| 2006 | 2 | 1 |
| 2007 | 2 | 2 |
| 2008 | 0 | 0 |
| 2009 | 2 | 0 |
| 2010 | 0 | 3 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 1 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Removal of sulfur from naphtha15 Oct 2019US 10,443,001 B2Uop LLC
- Photosensitive resin composition, oxime sulfonate compound, method for forming cured film, cured film, organic EL display device, and liquid crystal display device20 May 2014US 8,728,708 B2FUJIFILM Corporation
- Compositions and methods to control abnormal cell growth17 May 2011US 7,943,606 B2CanCure Laboratories, LLC
- Compounds and compositions to control abnormal cell growth15 Sep 2009US 7,589,083 B2CanCure Laboratories, LLC
- Resist composition, compound for use in the resist composition and pattern forming method using the resist composition2 Jun 2009US 7,541,131 B2FUJIFILM Corporation
- Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device1 May 2025US 2025/0136569 A1Idemitsu Kosan Co., Ltd.
- Removal of sulfur from naphtha3 May 2018US 2018/0119032 A1Uop LLC
- Pharmaceutical composition for the treatment and prevention of cardiac disease5 Jun 2014US 2014/0154319 A1
- Pharmaceutical composition for treatment and prevention of kidney diseases14 Nov 2013US 2013/0302422 A1Kt&G Corporation
- Photosensitive resin composition, oxime sulfonate compound, method for forming cured film, cured film, organic el display device, and liquid crystal display device4 Jul 2013US 2013/0171415 A1FUJIFILM Corporation
Most cited
By later US patents
- Heterocycle-containing carbonic acid derivatives96US 5,612,356 AEisai Co., Ltd. · 1997
- Benzo1,2-g!-chrom-3-ene and benzo1,2-g!-thiochrom-3-ene derivatives75US 5,728,846 AAllergan, Inc. · 1998
- Benzo[1,2-G]-chrom-3-ene, and benzo[1,2-G]-thiochrom-3-ene derivatives38US 6,087,505 AAllergan Sales, Inc. · 2000
- Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo [1,2-g]chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity37US 6,538,149 B1Allergan, Inc. · 2003
- Aryl substituted 3,4-dihydroanthracene derivatives having retinoid antagonist or retinoid inverse agonist type biological activity35US 7,166,726 B2Allergan, Inc. · 2007